|
|
|
|
|
|
|
Flector Tissugel ® approved by the FDA
(31.01.2007)
Flector Tissuegel®, IBSA’s patch containing 1.3% epolamine salt of diclofenac, has been approved by the FDA for the treatment of acute pain due to minor strains, sprains and contusion. The USA marketing authorisation enlightens another major achievement and a further confirmation of the expansion trend of the company.
|
|
|
|
|
|
|
türkçe
